Improving performance of an accountable care organization on a quality measure assessing β-blocker use in systolic heart failure.
CONCLUSION: The performance on a Medicare Pioneer ACO quality measure evaluating β-blocker use in systolic heart failure improved in a one-year period after a clinical pharmacist-generated initiative was implemented at Atrius Health practice sites.
PMID: 27543597 [PubMed - as supplied by publisher]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Elman S, Zaiken K Tags: Am J Health Syst Pharm Source Type: research
More News: Atenolol | Bisoprolol | Cardiology | Coreg | Drugs & Pharmacology | Education | Health | Heart | Heart Failure | Medicare | Metoprolol Tartrate | Toprol